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People with mental illness are more likely than the rest of the population to have physical health 
problems and to die prematurely. The Lancet Psychiatry Commission on protecting physical health 
in people with mental illness draws attention to this global inequality.1 
 
An issue clearly highlighted by the Commission is that we know less about the physical health of 
people with common mental disorders, like depression and anxiety, compared to people with 
severe mental illnesses (SMI). The risk of physical health problems and premature mortality 
compared to the general population is higher for people with SMI than for those with common 
mental disorders. For example, the odds of all-cause mortality is 2.5 times higher than the general 
population for people with schizophrenia and 1.7 times higher for people with depression.1 
However, an estimated 23 million people worldwide have schizophrenia, whereas 300 million 
people have depression.2 The population level impact in terms of life-years lost is therefore far 
higher in common mental disorders than SMI. The level of unmet need in physical healthcare in 
people with common mental disorders is not well quantified, but potentially eclipses the issues in 
SMI populations.  
 
Several research questions on morbidity and premature mortality remain unanswered for common 
mental disorders. One is whether the mortality gap between people with and without common 
mental disorders is increasing. Despite mortality rates decreasing in the population overall, the 
mortality gap between people with and without SMI is growing.3 Possible explanations for this are 
that interventions for negative health behaviours have been less effective at engaging people with 
mental health problems, that medications treating mental health problems detrimentally affect 
physical health, and that health effects of periods of economic recession have been larger in more 
socioeconomically disadvantaged groups. Through any/all of these mechanisms we could 
hypothesise that the mortality gap is also increasing for people with CMD compared to the general 
population.  
 
Another question is to what extent are people with common mental disorders at increased risk of 
infectious diseases compared to the general population? The Commission identified a lack of 
evidence on rates of infectious diseases among people with common mental disorders. In 
particular, there are few large nationally representative studies on the prevalence of different types 
of infectious diseases and few studies of common mental disorders and infectious diseases set in 
primary care, where the vast majority of people with depression are treated. For patients with SMI, 
HIV, hepatitis B and hepatitis C are between two and six times more common than in the general 
population.4 One reason for this could be increased substance misuse among people with SMI.4 
Drug use along with risky sexual behaviours5 are more common in people with depression and 
anxiety compared to the general population, and therefore we might expect similarly elevated rates 
of these infectious diseases in common mental disorders.  
 
Third, could primary care interventions reduce the risk of physical health problems in people with 
common mental disorders? Interventions targeting lifestyle risk factors like smoking,6  have been 
adapted for people with SMI. There have been 27 meta-analyses of physical health interventions 
for people with SMI and the seven trials of lifestyle interventions identified by the Commission were 
all in SMI populations.1 The development or adaptation of lifestyle interventions for people with 
common mental disorders appears to have lagged behind. This is despite evidence that people 
with common mental disorders experience higher rates of many negative health behaviours than 
the general population. Around 30% of people with depression7 and 20% of people with 
schizophrenia8 are likely to have an alcohol problem during their lifetime. Around 30% to 40% of 
people with depression are current smokers9 (and 60% to 70% of people with schizophrenia). 
Young people with depression are also at increased risk of many negative health behaviours,10 
which may have long-term health implications.  
 
The 2018 WHO guidelines recommend lifestyle interventions as first-line strategies for the 
management of physical health (including weight management, cardiovascular risk reduction, and 
diabetes treatment and prevention) in adults with SMI.1 [A: cite the guidelines here not the 
Commission]. There is no similar recommendation for people with common mental disorders. 
Overlooking populations with common mental disorders seems surprising (and neglectful) given 
the high prevalence of anxiety and depression and the evidence of association with lifestyle risk 
factors, morbidity and premature mortality. It is unclear if people with common mental disorders 
require modified approaches to risk factor management in line with SMI populations, but given the 
similar challenges this group faces it is reasonable to hypothesise that interventions need to be 
tailored to account for mental health issues. 
 
Closing the gap between our understanding of the physical health of people with common mental 
disorders and SMI should be a research priority. Whether mental illnesses cause, share common 
antecedents with, or complicate the treatment of physical health problems, improved care and 
prevention in people with common mental disorders could substantially reduce the prevalence of 
morbidity and burden on healthcare services. A vital need to improve healthcare in SMI 
populations, who are among the most vulnerable in society, remains. However, at a population and 
individual level, addressing the physical health needs of people with common mental disorders 
would have considerable benefit.  
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